EXHIBIT
Published on October 18, 2012
EXHIBIT 99.1
UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS
The following unaudited pro forma combined balance sheet and statements of operations are presented to give effect to the acquisition of Standard Microsystems Corporation (“Target”) by Microchip Technology Incorporated (“Company”). The pro forma information was prepared based on the historical financial statements and related notes of the Company and Target (which are incorporated by reference in this document), as adjusted for the pro forma impact of applying the purchase method of accounting in accordance with Generally Accepted Accounting Principles in the United States (“US GAAP”). The pro forma adjustments are based upon available information and assumptions that the Company believes are reasonable. The allocation of the purchase price of the Target acquisition reflected in these unaudited pro forma combined financial statements has been based upon preliminary estimates of the fair value of assets acquired and liabilities assumed. The pro forma adjustments are therefore preliminary and have been prepared to illustrate the estimated effect of the acquisition.
The unaudited pro forma combined balance sheet has been prepared to reflect the transaction as of June 30, 2012. The unaudited pro forma combined statements of operations combine the results of operations of the Company and Target for the fiscal year ended March 31, 2012 and the three months ended June 30, 2012 as if the transaction had occurred on April 1, 2011.
The unaudited pro forma combined financial statements have been prepared for illustrative purposes only and are not necessarily indicative of the consolidated financial position or results of operations in future periods or the results that actually would have been achieved had the Company and Target been a combined company during the respective periods presented. These unaudited pro forma combined financial statements should be read in conjunction with the Company’s historical consolidated financial statements and related notes included in its Form 10-K for the fiscal year ended March 31, 2012 filed on May 30, 2012 and in its Form 10-Q for the period ended June 30, 2012 filed on August 9, 2012 as well as Target’s historical consolidated financial statements and related notes included in its Form 10-K for the fiscal year ended February 29, 2012 filed on April 23, 2012 and in its Form 10-Q for the period ended May 31, 2012 filed on July 3, 2012.
The unaudited pro forma combined financial statements were prepared using the purchase method of accounting with the Company treated as the acquiring entity. Accordingly, the aggregate value of the consideration paid by the Company to complete the acquisition will be allocated to the assets acquired and liabilities assumed from Target based upon their estimated fair values on the closing date of the acquisition. As of the date of this Form 8-K/A, the Company has not completed the detailed valuations necessary to estimate the fair value of the assets acquired and the liabilities assumed from Target and the related allocations of purchase price, nor has the Company identified all adjustments necessary to conform Target’s accounting policies to the Company’s accounting policies. Additionally, a final determination of the fair value of assets acquired and liabilities assumed from Target will be based on the actual net tangible and intangible assets and liabilities of Target that existed as of the closing date. Accordingly, the pro forma purchase price adjustments presented herein are preliminary, and may not reflect any final purchase price adjustments made. These pro forma purchase price adjustments have been made solely for the purpose of providing the unaudited pro forma combined financial statements required pursuant to Item 9.01 of Form 8-K. The Company estimated the fair value of Target’s assets and liabilities based on discussions with Target’s management, due diligence and preliminary work performed by third-party valuation specialists. As the final valuations are being performed, increases or decreases in the fair value of relevant balance sheet amounts will result in adjustments, which may result in material differences from the information presented herein.
The Company expects to incur costs and realize benefits associated with integrating the operations of the Company and Target. The unaudited pro forma combined financial statements do not reflect the costs of any integration activities or any benefits that may result from operating efficiencies or revenue synergies.
1
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES | |||||||||||||
PRO FORMA COMBINED BALANCE SHEET | |||||||||||||
(in thousands, except share and per share amounts) | |||||||||||||
(unaudited) | |||||||||||||
ASSETS | |||||||||||||
Microchip |
SMSC |
Total |
Pro Forma |
||||||||||
June 30, |
May 31, |
Pro Forma |
June 30, |
||||||||||
2012 |
2012 |
Adjustments |
2012 |
||||||||||
Cash and cash equivalents |
$ |
779,848 |
$ |
161,824 |
$ |
(312,701 |
) |
(a) |
$ |
628,971 |
|||
Short-term investments |
881,913 |
- |
- |
881,913 |
|||||||||
Accounts receivable, net |
174,685 |
60,399 |
- |
235,084 |
|||||||||
Inventories |
221,481 |
37,623 |
50,000 |
(b) |
309,104 |
||||||||
Prepaid expenses |
25,588 |
- |
- |
25,588 |
|||||||||
Deferred tax assets |
94,968 |
19,610 |
4,000 |
(c) |
118,578 |
||||||||
Other current assets |
50,815 |
9,496 |
- |
60,311 |
|||||||||
Total current assets |
2,229,298 |
288,952 |
(258,701 |
) |
2,259,549 |
||||||||
Property, plant and equipment, net |
506,229 |
62,063 |
- |
568,292 |
|||||||||
Long-term investments |
159,476 |
27,647 |
- |
187,123 |
|||||||||
Goodwill |
102,193 |
113,050 |
31,042 |
(d) |
246,285 |
||||||||
Intangible assets, net |
110,257 |
27,960 |
490,840 |
(e) |
629,057 |
||||||||
Other assets |
37,387 |
11,790 |
- |
49,177 |
|||||||||
Total assets |
$ |
3,144,840 |
$ |
531,462 |
$ |
263,181 |
$ |
3,939,483 |
|||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||
Accounts payable |
$ |
52,646 |
$ |
21,354 |
$ |
- |
$ |
74,000 |
|||||
Accrued liabilities |
86,550 |
79,209 |
(26,982 |
) |
(f) |
138,777 |
|||||||
Deferred income on shipments to distributors |
110,793 |
18,659 |
(18,659 |
) |
(g) |
110,793 |
|||||||
Total current liabilities |
249,989 |
119,222 |
(45,641 |
) |
323,570 |
||||||||
Junior convertible debentures |
357,355 |
- |
- |
357,355 |
|||||||||
Long-term income tax payable |
73,261 |
- |
58,622 |
(c) |
131,883 |
||||||||
Deferred tax liability |
416,980 |
- |
35,000 |
(c) |
451,980 |
||||||||
Line of credit |
- |
- |
600,000 |
(a) |
600,000 |
||||||||
Other long-term liabilities |
29,265 |
20,540 |
- |
49,805 |
|||||||||
Stockholders' equity: |
|||||||||||||
Preferred stock |
- |
- |
- |
- |
|||||||||
Common stock |
194 |
2,898 |
(2,898 |
) |
(h) |
194 |
|||||||
Additional paid-in capital |
1,269,607 |
399,833 |
(392,933 |
) |
(h) |
1,276,507 |
|||||||
Retained earnings |
1,510,326 |
120,790 |
(120,790 |
) |
(h) |
1,510,326 |
|||||||
Accumulated other comprehensive income (loss) |
2,963 |
1,585 |
(1,585 |
) |
(h) |
2,963 |
|||||||
Treasury stock, at cost |
(765,100 |
) |
(133,406 |
) |
133,406 |
(h) |
(765,100 |
) |
|||||
Total stockholders' equity |
2,017,990 |
391,700 |
(384,800 |
) |
2,024,890 |
||||||||
Total liabilities and stockholders' equity |
$ |
3,144,840 |
$ |
531,462 |
$ |
263,181 |
$ |
3,939,483 |
2
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES | |||||||||||||
PRO FORMA COMBINED STATEMENTS OF INCOME | |||||||||||||
(in thousands, except per share amounts) | |||||||||||||
(Unaudited) | |||||||||||||
Microchip
Twelve Months Ended March 31,
|
SMSC
Twelve Months Ended February 29,
|
Total
Pro Forma Adjustments
|
Pro Forma Twelve Months Ended
March 31,
|
||||||||||
2012 |
2012 |
2012 |
|||||||||||
Net sales |
$ |
1,383,176 |
$ |
412,104 |
$ |
(10,000 |
) |
(a) |
$ |
1,785,280 |
|||
Cost of sales |
590,782 |
196,446 |
71,371 |
(b) |
858,599 |
||||||||
Gross profit |
792,394 |
215,658 |
(81,371 |
) |
926,681 |
||||||||
Operating expenses: |
|||||||||||||
Research and development |
182,650 |
100,350 |
5,543 |
(c) |
288,543 |
||||||||
Selling, general and administrative |
212,391 |
86,706 |
44,874 |
(d) |
343,971 |
||||||||
Special charges |
837 |
608 |
- |
1,445 |
|||||||||
395,878 |
187,664 |
50,417 |
633,959 |
||||||||||
Operating income |
396,516 |
27,994 |
(131,788 |
) |
292,722 |
||||||||
Losses on equity method investments |
(195 |
) |
- |
- |
(195 |
) |
|||||||
Other income (expense): |
|||||||||||||
Interest income |
17,992 |
301 |
- |
18,293 |
|||||||||
Interest expense |
(34,266 |
) |
(155 |
) |
(12,000 |
) |
(e) |
(46,421 |
) |
||||
Other, net |
(352 |
) |
86 |
- |
(266 |
) |
|||||||
Income before income taxes |
379,695 |
28,226 |
(143,788 |
) |
264,133 |
||||||||
Income tax provision |
42,990 |
17,564 |
(19,964 |
) |
(f) |
40,590 |
|||||||
Net income |
$ |
336,705 |
$ |
10,662 |
$ |
(123,824 |
) |
$ |
223,543 |
||||
Basic net income per common share |
$ |
1.76 |
$ |
1.16 |
|||||||||
Diluted net income per common share |
$ |
1.65 |
$ |
1.09 |
|||||||||
Basic common shares outstanding |
191,283 |
192,083 |
|||||||||||
Diluted common shares outstanding |
203,519 |
204,319 |
3
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES | |||||||||||||
PRO FORMA COMBINED STATEMENTS OF INCOME | |||||||||||||
(in thousands, except per share amounts) | |||||||||||||
(Unaudited) | |||||||||||||
Microchip
Three Months Ended June 30,
|
SMSC
Three Months Ended May 31,
|
Total Pro Forma Adjustments |
Pro Forma Three Months Ended June 30, |
||||||||||
2012 |
2012 |
2012 |
|||||||||||
Net sales |
$ |
352,134 |
$ |
103,078 |
$ |
- |
$ |
455,212 |
|||||
Cost of sales |
149,055 |
46,902 |
4,143 |
(b) |
200,100 |
||||||||
Gross profit |
203,079 |
56,176 |
(4,143 |
) |
255,112 |
||||||||
Operating expenses: |
|||||||||||||
Research and development |
48,826 |
31,956 |
(5,296 |
) |
(c) |
75,486 |
|||||||
Selling, general and administrative |
57,920 |
44,202 |
(12,386 |
) |
(d) |
89,736 |
|||||||
Special charges |
- |
(794 |
) |
- |
(794 |
) |
|||||||
106,746 |
75,364 |
(17,682 |
) |
164,428 |
|||||||||
Operating income |
96,333 |
(19,188 |
) |
13,539 |
90,684 |
||||||||
Losses on equity method investments |
(121 |
) |
- |
- |
(121 |
) |
|||||||
Other income (expense): |
|||||||||||||
Interest income |
4,332 |
40 |
- |
4,372 |
|||||||||
Interest expense |
(9,148 |
) |
(28 |
) |
(3,000 |
) |
(e) |
(12,176 |
) |
||||
Other, net |
(532 |
) |
(70 |
) |
- |
(602 |
) |
||||||
Income before income taxes |
90,864 |
(19,246 |
) |
10,539 |
82,157 |
||||||||
Income tax provision |
12,154 |
(2,083 |
) |
3,185 |
(f) |
13,256 |
|||||||
Net income |
$ |
78,710 |
$ |
(17,163 |
) |
$ |
7,354 |
$ |
68,901 |
||||
Basic net income per common share |
$ |
0.41 |
$ |
0.35 |
|||||||||
Diluted net income per common share |
$ |
0.39 |
$ |
0.34 |
|||||||||
Basic common shares outstanding |
193,452 |
194,252 |
|||||||||||
Diluted common shares outstanding |
203,700 |
204,500 |
4
NOTES TO THE UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS
Adjustments to the pro forma combined balance sheet:
(a) This pro forma adjustment reflects the pro forma amount of cash paid for the transaction, less $600.0 million financed through the Company's existing line of credit.
(b) The pro forma adjustment to inventory reflects the fair value write-up of acquired inventory at the assumed acquisition date of approximately $50.0 million.
(c) The pro forma adjustments to deferred tax assets, long-term income taxes payable and deferred tax liabilities reflect the combination of the Company and the Target and the assessment of the tax attributes and tax liability exposure of the Target as of the assumed acquisition date.
(d) The pro forma adjustments to goodwill include the reversal of the Target's May 31, 2012 historical goodwill balance of approximately $113.0 million and the addition of approximately $144.0 million of goodwill as a result of the pro forma purchase price allocation.
(e) The intangible asset pro forma adjustments includes the reversal of the Target's May 31, 2012 historical intangible assets related to prior SMSC acquisitions of approximately $28.0 million and the addition of approximately $518.8 million as a result of the pro forma purchase price allocation.
(f) The pro forma adjustment to accrued liabilities includes the elimination of the Target's historical May 31, 2012 liability for stock appreciation rights in the amount of approximately $40.5 million, based upon the issuance of equity-based awards. Also included in the pro forma adjustment to accrued liabilities is approximately $13.5 million of estimated credits to be granted to distributors on the deferred margin adjustments described in (g) below.
(g) The pro forma adjustment to deferred income on shipments to distributors reflects the approximate amount of deferred margin recognized by the Target at May 31, 2012 which the Company will not recognize subsequent to the acquisition.
(h) The pro forma adjustments to equity includes the elimination of the Target's May 31, 2012 stockholders' equity amounts less approximately $6.9 million of transaction consideration related to pre-combination services of the Target's employee unvested shares converted to the Company's shares.
Adjustments to the pro forma combined statements of income:
(a) The pro forma adjustment to net sales reflects the reversal of revenue recognition for the sell-through of inventory held by the Target's distributors as of the assumed transaction date. The cost of sales related to this adjustment is noted in adjustment (b) below.
(b) The cost of sales pro forma adjustments are as follows:
Twelve months ended March 31, 2012 |
Three months ended June 30, 2012 |
|||||
(in thousands) |
||||||
Estimate of the fair value write-up of acquired inventory and its subsequent sale after the acquisition date |
$ |
50,000 |
$ |
— |
||
Elimination of Target's historical share-based compensation expense |
(661 |
) |
(2,158 |
) |
||
Addition of Company's share-based compensation for converted equity awards |
2,252 |
356 |
||||
Estimated amortization of acquired intangible assets |
23,780 |
5,945 |
||||
Cost of sales on distributor revenue recognition reversal |
(4,000 |
) |
— |
|||
Total pro forma cost of sales adjustments |
$ |
71,371 |
$ |
4,143 |
(c) The research and development expense pro forma adjustments are as follows:
5
Twelve months ended March 31, 2012 |
Three months ended June 30, 2012 |
|||||
(in thousands) |
||||||
Elimination of Target's historical share-based compensation expense |
$ |
(2,486 |
) |
$ |
(7,242 |
) |
Addition of Company's share-based compensation for converted equity awards |
8,029 |
1,946 |
||||
Total pro forma research and development expense adjustments |
$ |
5,543 |
$ |
(5,296 |
) |
(d) The selling, general and administrative expenses pro forma adjustments are as follows:
Twelve months ended March 31, 2012 |
Three months ended June 30, 2012 |
|||||
(in thousands) |
||||||
Elimination of Target's historical share-based compensation expense |
$ |
(5,055 |
) |
$ |
(18,601 |
) |
Addition of Company's share-based compensation for converted equity awards |
10,909 |
1,360 |
||||
Estimated amortization of acquired intangible assets |
39,020 |
4,855 |
||||
Total pro forma selling, general and administrative expense adjustments |
$ |
44,874 |
$ |
(12,386 |
) |
(e) The pro forma adjustment to interest expense relates to the interest charge on loans from the Company's existing credit facility as a result of the transaction. The interest was calculated using a 2% interest rate on $600 million of borrowings against the line of credit.
(f) The pro forma adjustments to income tax expense are as follows:
Assumed tax rate applied |
Twelve months ended March 31, 2012 |
Three months ended June 30, 2012 |
|||||||
(in thousands, except tax rates) |
|||||||||
Estimate of the fair value write-up of acquired inventory and its subsequent sale after the acquisition date |
25 |
% |
(1) |
$ |
(12,500 |
) |
$ |
— |
|
Elimination of Target's historical share-based compensation expense |
25 |
% |
(1) |
1,263 |
4,650 |
||||
Addition of Company's share-based compensation for converted equity awards |
25 |
% |
(1) |
(2,727 |
) |
(340 |
) |
||
Deferred margin adjustment |
25 |
% |
(1) |
(1,500 |
) |
— |
|||
Interest expense on line of credit |
37.5 |
% |
(2) |
(4,500 |
) |
(1,125 |
) |
||
Total pro forma cost of sales adjustments |
$ |
(19,964 |
) |
$ |
3,185 |
(1) 25% is the assumed tax rate of the Target's ongoing business activities.
(2) 37.5% is the assumed combined U.S. federal and state tax rate of the Target.
6